These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Comparative bioavailability studies on brands of diazepam tablets. Ogunbona FA, Adedoyin PA, Olaniyi AA. Afr J Med Med Sci; 1985; 14(1-2):21-5. PubMed ID: 2994433 [Abstract] [Full Text] [Related]
43. Pilot study on the absolute and relative bioavailability of Synthroid and Levothroid, two brands of sodium levothyroxine. Maxon HR, Ritschel WA, Volle CP, Eldon MA, Chen IW, Fernandez MF, Cline J, Mayfield G. Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):379-82. PubMed ID: 6688797 [Abstract] [Full Text] [Related]
44. Effect of formulation on dissolution and bioavailability of phenytoin tablets. Chakrabarti S, Belpaire F, Moerman E. Pharmazie; 1980 Aug; 35(10):627-9. PubMed ID: 7454745 [Abstract] [Full Text] [Related]
45. Effect of storage on the bioavailability of cephalexin from its capsules. Molokhia AM. Res Commun Chem Pathol Pharmacol; 1984 Aug; 45(2):219-24. PubMed ID: 6484309 [Abstract] [Full Text] [Related]
46. In vitro quality evaluation of leading brands of ciprofloxacin tablets available in Bangladesh. Uddin MS, Mamun AA, Hossain MS, Asaduzzaman M, Sarwar MS, Rashid M, Herrera-Calderon O. BMC Res Notes; 2017 May 30; 10(1):185. PubMed ID: 28558832 [Abstract] [Full Text] [Related]
47. [Relative bioavailability of paracetamol in suppositories preparations in comparison to tablets]. Blume H, Ali SL, Elze M, Krämer J, Wendt G, Scholz ME. Arzneimittelforschung; 1994 Dec 30; 44(12):1333-8. PubMed ID: 7848353 [Abstract] [Full Text] [Related]
50. Correlation of the bioavailability of diazepam from uncoated tablets in beagle dogs with its dissolution rate and bioavailability in humans. Ogata H, Aoyagi N, Kaniwa N, Koibuchi M, Shibazaki T, Ejima A, Shimamoto T, Yashiki T, Ogawa Y, Uda Y, Nishida Y. Int J Clin Pharmacol Ther Toxicol; 1982 Dec 30; 20(12):576-81. PubMed ID: 6818163 [Abstract] [Full Text] [Related]
53. [The biodisposition of paracetamol. I. The kinetics of disintegration of some dosage forms]. Abebe A, Chulia D, Verain A. Pharm Acta Helv; 1991 Dec 30; 66(2):56-9. PubMed ID: 1758894 [Abstract] [Full Text] [Related]
56. Factors affecting the bioavailability of phenytoin. Neuvonen PJ, Pentikäinen PJ, Elfving SM. Int J Clin Pharmacol Biopharm; 1977 Feb 30; 15(2):84-9. PubMed ID: 577918 [Abstract] [Full Text] [Related]
57. The bioavailability of alpha-acetyldigoxin from Card-Hydergin--a fixed combination of Hydergine and acetyldigoxin. Klotz U. Int J Clin Pharmacol Biopharm; 1978 Mar 30; 16(3):116-8. PubMed ID: 649228 [Abstract] [Full Text] [Related]
58. Bioavailability of doxycycline from dissolved doxycycline hydrochloride tablets--comparison to solid form hydrochloride tablets and dissolved monohydrate tablets. Saano V, Paronen P, Peura P. Int J Clin Pharmacol Ther Toxicol; 1990 Nov 30; 28(11):471-4. PubMed ID: 2272707 [Abstract] [Full Text] [Related]
59. [The bioavailability of paracetamol II. The effect of porosity and mechanical properties of the dosage form on solubility]. Abebe A, Chulia D, Verain A. Pharm Acta Helv; 1991 Nov 30; 66(3):83-7. PubMed ID: 1763092 [Abstract] [Full Text] [Related]
60. The biopharmaceutical properties of solid dosage forms. I. An evaluation of 23 brands of phenylbutazone tablets. Searl RO, Pernarowski M. Can Med Assoc J; 1967 Jun 10; 96(23):1513-20. PubMed ID: 6026336 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]